SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022650
Filing Date
2017-11-08
Accepted
2017-11-08 14:48:49
Documents
90
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-10q_20170930.htm 10-Q 1847802
2 EX-10.1 mygn-ex101_186.htm EX-10.1 12888
3 EX-10.2 mygn-ex102_187.htm EX-10.2 17458
4 EX-31.1 mygn-ex311_8.htm EX-31.1 15851
5 EX-31.2 mygn-ex312_7.htm EX-31.2 16319
6 EX-32.1 mygn-ex321_6.htm EX-32.1 6528
  Complete submission text file 0001564590-17-022650.txt   8405340

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20170930.xml EX-101.INS 2187496
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20170930.xsd EX-101.SCH 53946
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20170930_cal.xml EX-101.CAL 74269
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20170930_def.xml EX-101.DEF 140519
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20170930_lab.xml EX-101.LAB 393482
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20170930_pre.xml EX-101.PRE 321692
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 171186241
SIC: 2835 In Vitro & In Vivo Diagnostic Substances